Indivior to acquire drug overdose therapies developer Opiant for $145m
Indivior will acquire Opiant at a price of $20 per share, for around $145m, in addition to $8…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
16 Nov 22
Indivior will acquire Opiant at a price of $20 per share, for around $145m, in addition to $8…
08 Nov 22
The combined company will leverage VillageMD’s expertise in value-based care and Summit Health-CityMD’s expertise in multispecialty, connected care…
02 Nov 22
The transaction, which has been unanimously approved by boards of directors of both companies, is expected to be…
07 Sep 22
The European regulator found that the acquisition would provide Illumina with the ability and incentive to prevent GRAIL’s…
06 Sep 22
With more than 10,000 clinicians across all 50 states and a nationwide provider network of more than 50…
29 Jul 22
The acquisition will complement BD’s technology pharmacy solutions and further advance its smart, customisable, connected care platform to…
PharmaceuticalsHealthcare ITPharmaceutical Compliance Software
22 Jul 22
One Medical provides in-person care, along with digital health and virtual care services, allowing patients to schedule appointments,…
14 Jul 22
The acquisition enables Infosys to provide the global life sciences companies with cloud-first digital platforms and data, strengthen…
12 Jul 22
The agreement follows the US Food and Drug Administration (FDA) lifting the clinical hold on the Phase 1/2…
15 Mar 22
Shoppers Drug Mart will add Lifemark to its team working in pharmacies, medical clinics, and healthcare businesses, to…